Artificial intelligence capable of predicting diseases years before diagnosisRead more...
8 startups will be pitching their ideas to some of the top healthtech VCs!
Vator Splash Health is finally here! And in just a few hours, we'll find out who the winner of our competition is!
The winning company, and the runner up, gets about $25,000 of in-kind prizes, a video of their presentation; a bottle of Bread and Butter wine, more TBD; plus sit-down meetings with at least 10 health tech VCs, including Maveron, Canaan Partners, Subtraction Capital, XFund, Kleiner Perkins, Efficient Capacity and more. They also get a round-trip flight on Surf Air.
Since Vator began its startup competitions more than 5 years ago, it has put 165 startups on stage. Since then, they've collectively raised nearly $400 million in follow-on capital.Past Vator winners have gone on to raise $100 million in follow-on capital. Among them are RelayRides, Udemy, Thumbtack, Getable, PokitDok, DogVacay, and Traxo, to name a few. We look forward to watching the progress of the next 10 we put on stage.
At the end of the night, the judges will vote for their favorite! That startup will be the Vator Splash Winner.
Here are the startups vying to win Vator Splash Health!
Multisensor Diagnostics’ rapid medical assessment (RMA) and AI- powered triage system is a powerful, convenient, cost- effective solution that helps improve access, increase adherence, avoid readmissions, detect early symptoms, and ultimately empower consumers.
Its RMA device, MouthLab, rapidly measures respiratory-rate, pulse-rate, electrocardiogram, SpO2, temperature, blood pressure, and lung functions, through the mouth, in less than a minute. The company's software supports seamless connectivity with providers, payers, patients, and caregivers, and unifies all aspects of patients’ health in a single place.
The presenter will be founder Sathya Elumalai.
Catalia Health is a patient care management company that provides an effective, scalable, AI-powered patient engagement platform for individuals managing chronic disease or taking medications on an ongoing basis. The company combines the efficacy of conversations tailored to individual patients with the cost efficiency of scalable technology. By combining proprietary artificial intelligence algorithms for generating conversations with the patented advantage of social robots,
The company has raised $1.35 million from Khosla Ventures.
The presenter will be founder Cory Kidd.
Amicomed is the first fully digital platform for Blood Pressure (BP) management combining innovative remote monitoring and lifestyle intervention. Amicomed leverages proprietary algorithms to provide tangible outcomes through innovative management of chronic diseases. The platform supports physicians with remote monitoring tools enhanced by vitals pattern analysis, and actionable, consumer-grade designed, personalized lifestyle intervention for their patients. The platform has been designed to manage all main cardiovascular conditions; BP is the first.
Through the platform, Care providers pay $33 per month, or $150 for three months. In three months, Amicomed believes it can reduce blood pressure.
The presenter will be founder Giangiacomo Rocco di Torrepadula.
Orphidia is a healthcare startup reinventing the laboratory blood diagnostics landscape by developing a marketplace platform for on- demand lab tests. It is developing a portable, blood diagnostic platform which performs lab-quality blood tests providing results for 40 different biomarkers in 20 minutes anywhere.
The presenter will be founder Aron Rachamim.
Invivox solves a global healthcare challenge: Continuous Training of Physicians. Invivox is a global medical platform that connects medical experts and practitioners in view of offering on-site (inside the operating room), one-to-one practical training sessions alongside experts. Invivox reinvents medical mentoring, which is the basis of the transmission of knowledge between physicians. Practically speaking, medical experts open their OR to other surgeons from around the world who travel to attend live training on-site.
Launched in September 2016, it has generated $300,000 in revenue to-date. It is approaching 1,000 trainers, and has connected 300 students. The company also raised $1.3 million.
The presenter will be founder Julien Delpech.
Blumio is targeting people who are hypertensive or who are at risk of developing hypertension. Benefits abound when continuous blood pressure monitoring is employed in the management of hypertension, as it gives insights into how blood pressure is responding to medication, exercise, and diet. Blumio will empower patients with the feedback they need to understand what works for them as an individual and implement change.
The presenter will be founder Catherine Liao.
GYANT is a health assistant that leads patients from their symptoms to the likely condition and the next steps by asking questions and learning from the answers, like a doctor would do - but through AI. Its first product is a checker for the Zika virus that had close to 300k users since its launch end of August.
The company is seeing 60,000 to 70,000 users a month and is adding 30,000 a month.
The presenter will be founder Pascal Zuta.
Iris Plans delivers Advance Care Planning (ACP) services via telehealth to people facing serious illness. Our ACP solution significantly reduces unnecessary care, a $210B problem that creates waste and human suffering. The Iris Plans platform allows our healthcare professionals to meet by video/phone with patients and their families. The platform also customizes the ACP process to the patient’s medical conditions and unique circumstances, ultimately producing official healthcare directives and a plan to guide major healthcare decisions.
It is reaching 110 physicians who oversee 200000 patients. The company has already served 500 patients. It has raised $1 million from Better Ventures and angels.
The presenter will be founder Steve Wardle.
Our judges include: Ryan Howard (Founder, iBeat and Practice Fusion; Angel investor); Risa Stack (General Manager, GE Ventures); Emily Melton (Partner, DFJ Venture); Paul Willard (Partner, Subtraction Capital); Hubert Zajicek (CEO, Health Wildcatters); Lyon Wong (Co-Founder & General Partner, Spectrum 28); Lynne Chou (Partner, Kleiner Perkins); Erin Flynn (Managing Director, Vator Investment Club); Nico Arcino (Digital Health Strategies, Kaiser Permanente); David Wu (General Partner, Maveron)
Read more from our "The Future of Healthcare" series
As tech tumbles, tech giants' moves into healthcare are being overlookedRead more...
A conversation with Eva Borden, Senior Managing Director, Behavioral and Medical Solutions at CignaRead more...
Related Companies, Investors, and Entrepreneurs
Joined Vator on
Catalia Health is a patient care management company that provides an effective, scalable, AI-powered patient engagement platform for individuals managing chronic disease or taking medications on an ongoing basis.
Imagine if every patient with chronic disease could have their own personalized wellness coach available around the clock to support them with their healthcare journey. This is now possible with the Mabu wellness coach platform. Mabu is an affordable companion robot that can have conversations with patients in their home regarding their healthcare & well being.
Mabu is unique in that she incorporates psychology, evidenced-based medicine, & artificial intelligence to create engaging daily conversations that are tailored for each patient’s personality & needs. An individual talks with Mabu similarly to how they interact with other voice or screen activated virtual assistants like Siri or Amazon Echo. However, unlike these assistants, Mabu remembers information, learns about the patient & personalizes conversations accordingly. Her conversations incorporate the patient’s condition & treatment as well as the psycho-social aspects of their disease. Conversations may address how they're feeling, their medication schedule, or mitigating treatment side effects. In addition, Mabu also offers tips for managing anxiety, depression, nutrition & daily activities.
These conversations happen largely through voice-based interactions, but are also through text, mobile, and web interfaces when patients are on the go. Together, these conversations delivered through a physical robot create a deeper relationship and are available any time patients need support. The data reported back through the system gives Catalia Health’s customers valuable information in order to better understand the daily activities & needs of their patients.
Mabu’s ability to transmit data via APIs allows Catalia Health to work with healthcare systems, payers, pharmacies, and pharmaceutical companies to enhance the reach of existing care management programs and close the gaps in care. The result is a better quality of life for the patient, lower costs for the patient and healthcare system, and more positive health outcomes overall.
We will be commercially launching our platform for patients with rheumatoid arthritis and kidney cancer by early summer 2017 and a platform for congestive heart failure by late fall 2017.
Joined Vator on
Iris Plans reduces the cost of complex care by 25% with our Advance Care Planning (ACP) solution for health insurers and at-risk providers. We dramatically reduce unnecessary care delivered to patients facing serious illness - a focused population that drives significant spending. Our telehealth platform allows Iris healthcare professionals to meet with patients and their families anytime, anywhere, creating a plan to guide major healthcare decisions. We have decades of palliative care experience and deliver a targeted offering at considerably lower cost than a traditional palliative program.
Joined Vator on
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients. Multisensor Diagnostics’ rapid medical assessment (RMA) and triage system is a powerful, convenient, cost- effective solution that aims to help improve access to care, increase medication adherence, reduce costs, avoid readmissions, detect early symptoms, and ultimately empower consumers to make intelligent decisions about their own health care. Our RMA device, MouthLab, rapidly measures breathing rate, pulse rate, electrocardiogram, SpO2, temperature, blood pressure, FEV1 and FEV1/FVC lung function, and breathing pattern, through a singular source - the mouth, at a fraction of the cost compared to other devices, in less than a minute. Our software supports seamless connectivity with providers, payers, caregivers, and integrates all the aspects of patients’ health in a single platform. Our triage system includes a secure HIPPA compliant communication system that provides patients real- time access to PCPs, telehealth providers, specialists and retail clinics. Unlike other disease management firms, we provide a single device and supporting technologies to perform comprehensive health assessment and triaging services. MouthLab is supplemented by distinctive features, such as compactness, asepticism with detachable mouthpieces (for multiusers), non-invasiveness, patent- protection, time-efficiency, cost-consciousness, and is focused on singularity of source for convenience. With the addition of biometrics, predictive analytics, machine learning, artificial intelligence and in-built communication capabilities, Multisensor Diagnostics is strongly poised to capture all age groups.
Joined Vator on
Khosla Ventures offers venture assistance, strategic advice and capital to entrepreneurs. The firm helps entrepreneurs extend the potential of their ideas in both traditional venture areas like the Internet, computing, mobile, and silicon technology arenas but also supports breakthrough scientific work in clean technology areas such as bio-refineries for energy and bioplastics, solar, battery and other environmentally friendly technologies. Vinod was formerly a General Partner at Kleiner Perkins and founder of Sun Microsystems. Vinod has been labeled the #1 VC by Forbes and Fortune recently labeled him as one the nation's most influential ethanol advocates, noting "there are venture capitalists, and there's Vinod Khosla." Vinod Khosla founded the firm in 2004.
Joined Vator on
Invivox is a worldwide medical platform that connects medical experts and practitioners in view of offering on-site (inside the operating room), one-to-one practical training sessions alongside experts.
Invivox reinvents medical mentoring, which is the basis of the transmission of knowledge between physicians.
Practically speaking, medical experts open their OR to other surgeons from around the world.
On one hand, Experts set the dates, the number of physicians they can accomodate in their OR and the price per participant.
On the other hand, surgeon can look for a specific training, register and pay on line and then travel to the place of the Expert for a real live mentoring experience.
According to physicians, there is no better way to acquire a new technique.
Joined Vator on
Practice Fusion provides a free, web-based EMR system to physicians. With medical charting, scheduling, e-prescribing (eRx), lab integrations, referral letters, Meaningful Use certification, unlimited support and a Personal Health Record for patients, Practice Fusion's EMR the complex needs of today's healthcare providers and disrupts the health IT status quo. Practice Fusion is the fastest growing Electronic Medical Record community in the country with more than 150,000 users serving 40 million patients. The company closed a $23 million Series B round of financing led by Founders Fund in 2011. For more information about Practice Fusion, please visit www.practicefusion.com
Joined Vator on
Blumio has developed a sensor that can continuously monitor one of our most important vital signs – blood pressure – without requiring an inflatable cuff. Designed for all day wear, Blumio’s novel sensor technology can measure blood pressure noninvasively and continuously, by capturing and analyzing arterial movements in a new way, providing the ability to gain contextual insights into this important biomarker and opening a new window into our understanding of heart health.
Joined Vator on
Orphidia is a healthcare startup reinventing the laboratory blood diagnostics landscape by developing a marketplace platform for on-demand lab tests. We are developing a portable, blood diagnostic platform which performs lab-quality blood tests providing results for 40 different biomarkers in 20 minutes anywhere.
Joined Vator on
GYANT is a health assistant that leads patients from their symptoms to the likely condition and the next steps by asking questions and learning from the answers, like a doctor would do - but through AI. Our first product is a checker for the Zika virus that had close to 300k users since its launch end of August.
Joined Vator on
Subtraction Capital is an opportunistic venture fund that works hard to support great entrepreneurs. We believe that we have an eye for spotting valuable companies early in their lifecycle, but we also invest in mid and late stage companies that have proven track records and more established teams.
Joined Vator on
Amicomed is the first fully automated digital therapeutics platform for Blood Pressure (BP) management combining innovative remote monitoring and lifestyle intervention.
Amicomed leverages proprietary algorithms to provide tangible outcomes through innovative management of blood pressure. The platform supports physicians and patients with remote monitoring tools enhanced by unprecedented blood pressure data analysis, and an actionable, consumer-grade designed, personalized lifestyle intervention.
Amicomed's results have been striking: 70% adherence with a mean BP reduction (sys) of 5mmHg (up to 20mmHg) with seven proof points at major international congresses (American Heart Association, American Society of Hypertension, American College of Cardiology, European Society of Hypertension, etc).
Joined Vator onDr. Cory Kidd is the founder and CEO of Catalia Health, a healthcare technology company that delivers effective patient engagement and behavior change. He's a serial entrepreneur who has been working in healthcare technology for nearly two decades.
Joined Vator onSerial entrepreneur passionate for startups. MBA (Bocconi), McKinsey. In 2000 cofounded Pharmaidea (at his exit fully profitable, €150 mln rev, and 150 employees). Now cofounder and CEO of Amicomed, digital platform for blood pressure management
Joined Vator onMarried, 3 kids. 20 years of experience in the Medical Device industry located in Moscow, Buenos Aires, Mexico city, London. Launched Invivox in 2015 when I realized Medical Mentoring was not efficient anymore. It had to be reinvented. We did it.
Joined Vator onManaging Partner - Vator Investment Club; Early-stage startup advisor with over 15-years experience in business and corporate development for internet brands including Travelocity, Epicurious, Concierge.com, Wired and Style.com.
Joined Vator onCo-founded Health Wildcatters, which I also run. I specialize in healthcare companies / startups (digital health/ mHealth / medical device companies) where I have spent most of my time.
Joined Vator onI started my career in investment banking and have since run an international organization, led a successful bank turnaround, launched and directed a debt/equity fund and chaired several boards & committees. Also a proud Blue Devil (Duke MBA).
Joined Vator onI joined my first technology startup at 19, as a systems engineer for one of the first Internet conferencing services in the 90s. Since then, I've held roles ranging from tech ops to tech sales & biz dev to product management & marketing.
Joined Vator onI have founded companies all my life. A film production company (sold), a social network (shut down), an ecommerce company (40m+ revenue, 25% margin). I was an early employee and later CEO of Aeria Games (exit to ProSieben AG). Cofounder of GYANT.
Joined Vator onLyon Wong is Co-Founder of Spectrum 28,with a focus on industries under going massive change. Investor in Plangrid, Earnest, Freenome, Dynasty and more. Previously at Lightspeed and Meritech. Lyon has 30+ patents and went to Stanford and Waterloo. .